Tag: Peripheral arterial disease

BD announces first patient enrolled in PAD vascular covered stent trial

BD has announced the enrolment of the first patient in the AGILITY investigational device exemption (IDE) study, which will assess the safety and effectiveness...

Sensome initiates trial assessing tissue microsensor technology in peripheral arterial disease

Sensome has announced enrolment of the first patients into a feasibility clinical study using the Clotild smart guidewire in peripheral arterial disease (PAD). Clotild was...
Auryon

AngioDynamics announces US FDA 510(k) clearance of Auryon XL radial access...

AngioDynamics today announced that the US Food and Drug Administration (FDA) has cleared the Auryon XL catheter, a 225cm radial access catheter, for use with...
Detour

Endologix announces results of pooled analysis of DETOUR1 and DETOUR2 Studies...

Endologix has announced results from a pooled analysis of the DETOUR1 and DETOUR2 studies evaluating percutaneous transmural arterial bypass (PTAB) with the Detour system. A...
agreement

LimFlow announces agreement to be acquired by Inari Medical

LimFlow announced today that it has entered into a definitive agreement to be acquired by Inari Medical. A press release details that, under the terms...
patient-level

TCT 2023: First presentation of complete patient-level dataset on paclitaxel and...

Data from a patient-level meta-analysis—a factor in the US Food and Drug Administration’s (FDA) recent change of position on the use of paclitaxel-coated devices...

Cardio Flow announces US FDA 510(k) clearance for its FreedomFlow orbital...

Cardio Flow recently announced it has received US Food and Drug Administration (FDA) 510(k) clearance for the company’s FreedomFlow orbital atherectomy peripheral platform. The company...

FDA update: Paclitaxel-coated devices for PAD cleared of excess mortality risk,...

This advertorial is sponsored by Boston Scientific. Data on hundreds of thousands of patients who have received lower limb endovascular treatment provide confidence in paclitaxel...

SCAI welcomes FDA decision to remove red flag for use of...

The president of the Society for Cardiovascular Angiography & Interventions (SCAI), George Dangas (Icahn School of Medicine at Mount Sinai, New York, USA), has...

Boston Scientific announces position on FDA update about use of paclitaxel-coated...

Following yesterday's news that the US Food and Drug Administration (FDA) has changed its stance on the use of paclitaxel-coated devices to treat peripheral...

FDA removes red flag for paclitaxel-coated devices after review finds data...

In a letter to healthcare providers dated 11 July 2023, the US Food and Drug Administration (FDA) communicates that the risk of mortality associated...

Black patients nearly 50% less likely to receive revascularisation for PAD

A new study from Keck Medicine at the University of Southern California (USC; Los Angeles, USA) has uncovered “significant racial disparities” in the diagnosis, treatment and outcomes of...
detour system

US FDA approves Endologix’s Detour system for treating complex PAD

Endologix has announced in a press release that the US Food and Drug Administration (FDA) has granted approval for the Detour system to treat...

Vascular News 98 – June 2023 US Edition

In this issue: Extensive coverage of CX 2023, including a full report of the BASIL-2 randomised controlled trial results New guidelines: Chris Twine (Bristol, UK)...

Vascular News 98 – June 2023

In this issue: Extensive coverage of CX 2023, including a full report of the BASIL-2 randomised controlled trial results New guidelines: Chris Twine (Bristol,...
mental health

New “biopsychosocial” roadmap set out to address PAD treatment and mental...

A recent proposal has called for “whole-person, multidisciplinary interventions” after an interrogation of the interplay between lower extremity peripheral arterial disease (PAD) and mental...
real-world

Real-world data consistent with RCTs in highlighting the efficacy of drug-eluting...

This advertorial is sponsored by Boston Scientific. During a recent satellite symposium, which took place at the 2022 Cardiovascular Interventional Radiological Society of Europe (CIRSE)...

BASIL-2 points towards endovascular-first revascularisation strategy in CLTI patients

A question from Manj Gohel (Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK) on what the Charing Cross (CX) audience should take back to...
Surmodics

Surmodics announces successful first patient use of Sublime radial access microcatheter...

Surmodics has announced that Ankur Lodha (Cardiovascular Institute of the South, Lafayette, USA) and Pradeep Nair (Cardiovascular Institute of the South, Houma, USA) were...
financing

AVS’ pulsatile IVL technology attracts an additional US$8.8 million to close...

AVS, an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease with its pulsatile intravascular lithotripsy (PIVL) therapy, has...
VOYAGER

New VOYAGER PAD analysis confirms consistent benefit of low-dose rivaroxaban plus...

Data from a new prespecified analysis of the phase III VOYAGER PAD clinical trial show that low-dose rivaroxaban plus aspirin resulted in a 33%...
Shockwave

Shockwave IVL: Sound science reinforced by sound evidence

This article forms part of an educational supplement sponsored by Shockwave Medical. Explore the full Compliance is Key series here. Stefano Fazzini (Tor Vergata Hospital,...
mental health

“Urgent action needed” to improve implementation of guideline-directed medical therapy for...

Almost one-half of the patients receiving a peripheral vascular intervention (PVI) in the Society for Vascular Surgery (SVS) Vascular Quality Initiative (VQI) registry between...

Jon Boyle

Following his 2021–2022 presidency of the Vascular Society of Great Britain and Ireland (VSGBI), Jon Boyle (Cambridge University Hospitals NHS Trust, Cambridge, UK) speaks...
top 10

Vascular News’ top 10 most popular stories of January 2023

January's top 10 highlights an individual patient data meta-analysis on the safety of carotid endarterectomy in the elderly and a new randomised trial on...

UK NVR annual report highlights “extremely high” case ascertainment rates despite...

The UK National Vascular Registry (NVR) recently published its 2022 annual report—the 10th since the registry was launched in 2013—highlighting important outcome data for...

The BeBack crossing catheter: A “game-changer” in endovascular PAD practice

This advertorial is sponsored by Bentley. Crossing chronic total occlusion (CTO) lesions are challenging procedures. The BeBack crossing catheter—Bentley’s first product to be available in...

“A very grey area”: EVOCC trial addresses best treatment option for...

Athanasios Saratzis (University of Leicester, Leicester, UK) speaks to Vascular News about the EVOCC trial, which he hopes will dispel patient and physician “uncertainty”...

Cardiovascular Systems enrols first patient in Japan for KAIZEN clinical study

Cardiovascular Systems Inc (CSI) recently announced initiation of the KAIZEN clinical study of its Diamondback 360 peripheral orbital atherectomy system (OAS) for the treatment...
top 10

Vascular News’ top 10 most popular stories of November 2022

November's top 10 includes the first results from BEST-CLI, as well as new data presented at this year's Vascular Interventional Advances (VIVA; 31 October–3...

VSGBI President’s Symposium spotlights data-driven financial incentives for PAD revascularisation

The President’s Symposium at the Vascular Society of Great Britain and Ireland (VSGBI) annual scientific meeting (23–25 November, Brighton, UK) featured Rob Sayers’ (University...
SIRONA

Concept Medical’s SIRONA trial completes enrolment

Concept Medical has announced the completion of patient enrolment in the SIRONA trial. According to the company, this is the world's first and the...
R2P

Terumo announces study results underscoring safety and efficacy of radial to...

Terumo Medical Corporation has announced late-breaking data showing the safety and efficacy of radial to peripheral (R2P) interventions with the R2P Misago self-expanding peripheral...
Selution

First US patient enrolled in Selution SLR IDE peripheral study

The first US patient has been enrolled in the US Food and Drug Administration (FDA) SELUTION4BTK (below-the-knee) clinical trial evaluating Selution SLR, MedAlliance's novel...

BD launches first-in-human trial of a peripheral sirolimus drug-coated balloon

BD has announced the start of enrolment in a first-in-human trial of a peripheral sirolimus drug-coated balloon (DCB). The PREVISION trial is a prospective, multicentre,...
top 10

Vascular News’ top 10 most popular stories of July 2022

July's top 10 most popular items include more from this year's Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM 2022; 15–18 June, Boston,...
Auryon

AngioDynamics announces FDA clearance of expanded indications for Auryon atherectomy system

AngioDynamics recently announced that it has received US Food and Drug Administration (FDA) 510(k) clearance of an expanded indication for the Auryon atherectomy system...

“No pain, no gain” approach improves walking ability with peripheral arterial...

Walking for exercise at a pace that induced pain or discomfort improved walking ability among people with peripheral arterial disease (PAD), according to new research...

Black adults treated for common arterial disease are at greater risk...

In a study recently published in Circulation, researchers found that Black adults underwent significantly more endovascular peripheral vascular interventions (PVI), were treated for more advanced...
Cordis

Cordis announces start of enrolment in RADIANCY clinical study in Europe

Cordis has announced the start of the RADIANCY premarket clinical study in Europe. A press release details that RADIANCY is a prospective, multicentre, single-arm...

Shockwave IVL: Maintaining options for patients with calcified PAD

 Intravascular Lithotripsy (IVL; Shockwave Medical) gives physicians “the option to treat a patient efficiently without implanting something like a stent, which would limit further...
Surmodics

Pounce thrombectomy system first-in-human data show 100% technical success in early...

Surmodics has announced that its Pounce thrombectomy system achieved 100% technical success in 20 first-in-human (FIH) procedures. The FIH data were presented by Gary...

Five-year patient-level data confirm safety of Passeo-18 Lux paclitaxel DCB

New long-term data presented at the 2022 Charing Cross (CX) Symposium (26–28 April, London, UK) demonstrate the safety of Biotronik’s Passeo-18 Lux paclitaxel drug-coated...
top 10

Vascular News’ top 10 most popular stories of March 2022

A review of intraoperative adverse events in patients treated with fenestrated and branched endovascular aneurysm repair, meta-analysis findings on peripheral arterial disease symptoms in...

Vascular News – CX Special Edition 2022 US

In this issue: What to expect from CX 2022 A year in profiles: Ali AbuRahma, Michael Jenkins, Joseph Bavaria, and Palma Shaw Vascular News debuts a...

Vascular News – CX Special Edition 2022 OUS

In this issue: What to expect from CX 2022 A year in profiles: Ali AbuRahma, Michael Jenkins, Joseph Bavaria, and Palma Shaw Vascular News...

New Janssen initiative aims to advance equitable care and address hidden...

Janssen has announced the launch of 'Save Legs. Change Lives. Spot Peripheral Artery Disease Now', a multi-year initiative aimed at creating urgency and action...

Ra Medical Systems reaches 100 enrolled subjects in pivotal atherectomy clinical...

Ra Medical Systems has announced the achievement of a milestone with the enrollment of 100 subjects in the pivotal clinical study, according to a...

Peripheral arterial disease symptoms differ between sexes, meta-analysis finds

In future peripheral arterial disease (PAD) research, clinicians should not consider men and women as a single population and should instead report their data...
CSI

Cardiovascular Systems announces development of IVL technology for the treatment of...

Cardiovascular Systems recently announced that it has made significant progress towards the commercialisation of intravascular lithotripsy (IVL) systems for the treatment of calcific coronary...
VOYAGER

VOYAGER PAD subanalysis highlights risks for claudicants undergoing revascularisation

Principal investigator of the VOYAGER PAD trial, Marc Bonaca (University of Colorado Anschutz Medical Campus, Aurora, USA) speaks to Vascular News about the latest data...
alio

Alio and Lifeline create partnership for dialysis access patient monitoring

Alio has announced a partnership with Lifeline Vascular Care in support of patients living with end-stage renal disease (ESRD). Alio leverages artificial intelligence (AI)...
AFX2

Endologix names Matthew Thompson president and CEO

Endologix has announced the appointment of Matthew Thompson as president and chief executive officer. Thompson will also join Endologix’s board of directors. Richard Mott,...
PAD

Hispanic adults with PAD access inpatient care most often via the...

Hispanic adults hospitalised for treatment of symptoms of peripheral arterial disease (PAD) were more likely to access this care by going to the emergency...

VIVA 2021: Consensus established for appropriate use of IVUS in peripheral...

A worldwide committee of 40 cross-speciality medical experts achieved the first-ever consensus for the appropriate use of intravascular ultrasound (IVUS) in peripheral vascular disease...

AHA scientific statement provides update on epidemiology, diagnosis, and management of...

The American Heart Association (AHA) has released a new scientific statement on lower extremity peripheral arterial disease (PAD), focusing on contemporary epidemiology, management gaps,...

Researchers recommend “timely interventions by specialists and guideline-based treatment” to reduce...

A population-based study from 2013 to 2015 in Germany has found that nearly one fifth of patients with peripheral arterial disease (PAD) did not...

Case report: Recanalisation of chronic iliofemoral venous occlusion in a patient...

This advertorial, sponsored by BD, is only available in selected countries and geographies. In this case report for Vascular News, experts outline the importance...

Nationwide study identifies sex disparities in long-term mortality after paclitaxel exposure

A German claims-based cohort study has revealed that—in 13,204 patients treated with a paclitaxel-coated device for peripheral arterial disease (PAD)—mortality differences were mostly attributable...
top 10

Vascular News’ top 10 most popular stories of June 2021

New data from Philips' TOBA II below-the-knee (BTK) clinical trial, physicians' call for the AMPREDICT decision support tool to be applied in clinical practice,...

Femoropopliteal bypass shows reintervention benefit over endovascular therapy for advanced premature...

Femoropopliteal bypass is associated with decreased reinterventions at one year compared to endovascular therapy in patients with advanced premature peripheral arterial disease (PAD). This...

ACC 2021: VOYAGER-PAD analysis shows totality of ischaemic events reduced following...

Rupert Bauersachs (Darmstadt, Germany) talks to Cardiovascular News about the VOYAGER-PAD trial, the results of which he presented at the American College of Cardiology’s...

XO Score scoring sheath platform wins medical design award

Transit Scientific today announced that its XO Score scoring sheath platform has been named a winner in the 2021 Medical Design Excellence Awards (MDEA)....
MagicTouch

Concept Medical releases status updates on SIRONA RCT

Concept Medical has released a series of status updates on their head-to-head SIRONA (Sirolimus versus paclitaxel drug-eluting balloon angioplasty in femoropopliteal diseases) randomised controlled...

PAD Task Force commends reintroduction of ARC Act in the USA...

Members of the peripheral arterial disease (PAD) Task Force—including the Association of Black Cardiologists (ABC), CardioVascular Coalition, CLI Global Society, Preventative Cardiovascular Nurses Association,...
Auryon

Micro Medical Solutions receives FDA breakthrough device designation for MicroStent vascular...

Micro Medical Solutions (MMS) recently announced that the US Food and Drug Administration (FDA) has granted breakthrough device designation for its MicroStent vascular stent....

Micro Medical Solutions receives FDA breakthrough device designation for MicroStent vascular...

Micro Medical Solutions (MMS) recently announced that the US Food and Drug Administration (FDA) has granted breakthrough device designation for its MicroStent vascular stent....

PAD-scan deemed cost-effective for PAD detection in patients with diabetes

Point-of-care duplex ultrasound (PAD-scan) is a cost-effective test for the detection of peripheral arterial disease (PAD) in patients with diabetes. This is the conclusion...
SonieVie

Acute kidney injury is associated with medium-term mortality following endovascular intervention...

Acute kidney injury is a common complication after intervention for peripheral arterial disease (PAD), and is associated with “medium-term mortality” following percutaneous transluminal angioplasty...
walking

Walking can relieve leg pain in people with peripheral arterial disease

Exercise can play an important role in treating peripheral arterial disease (PAD), a recent review from Amy Harwood (Centre for Sport and Exercise Life...

Infinity angioplasty balloon catheter completes first-in-human clinical trial

The Infinity Angioplasty Balloon Company announced today that its angioplasty balloon platform—the Infinity angioplasty balloon catheter—has successfully completed a first-in-human clinical trial. The platform was...

VOYAGER PAD supports “pharmaco-invasive” approach to optimise outcomes

Recent data from VOYAGER PAD showed no association between drug-coated device (DCD) use and mortality.  Given the absence of a safety signal, the current...
Dabra

Ra Medical Systems announces 10 subjects have been enrolled in its...

Ra Medical Systems has announced enrolment of the tenth subject in its pivotal clinical trial to evaluate the safety and effectiveness of the Dabra...
R3 Vascular

R3 Vascular completes Series A financing

R3 Vascular recently announced closing of its Series A financing round, including new equity investments of US$15 million and the conversion of US$2.8 million...
natural

Alucent Biomedical announces US$35 million Series B financing

Alucent Biomedical recently announced the close of a US$35 million Series B financing round led by a large multinational strategic investor and joined by...
Biotronik

CIRSE 2020: New clinical data support use of 4F devices for...

Outcomes of the BIO4AMB trial demonstrated that ambulatory treatment with 4­-French (4F) devices is a valid and safe option for endovascular treatment of lower...

First patient enrolled in FUTURE SFA study of MagicTouch sirolimus-coated balloon

Concept Medical has announced the enrolment of the first patient in the FUTURE SFA (Randomised controlled trial of first sirolimus coated balloon versus standard...

CMS grants additional reimbursement for the Eluvia drug-eluting vascular stent system

Boston Scientific announced that the US Centers for Medicare and Medicaid Services (CMS) granted a new technology add-on payment (NTAP) for the Eluvia drug-eluting...
PQ Bypass Detour

PQ Bypass receives FDA breakthrough device designation for its Detour system

PQ Bypass has announced that they received breakthrough device designation from the US Food and Drug Administration (FDA) for the Detour system. The Detour...

Philips to expand its image-guided therapy portfolio through acquisition of Intact...

Royal Philips today announced that it has signed an agreement to acquire Intact Vascular. According to a press release, Intact Vascular will enhance Philips’...

High level of heterogeneity found in randomised PAD trial antithrombotic regimens

A recent systematic review showed that randomised trials comparing different types of peripheral endovascular arterial intervention have a high level of heterogeneity in their...
Auryon

First patient enrolled in PATHFINDER I registry examining Auryon atherectomy system

AngioDynamics has announced the enrolment of the first patient in the PATHFINDER I postmarket registry. The PATHFINDER I registry is a pilot study to evaluate...

PRIZER, new multicentre PAD study, launches

A new post-market study investigating the effectiveness of the Renzan peripheral stent system (Terumo) in patients with peripheral arterial disease (PAD) has been...

iVascular launches Sergeant peripheral support catheter

iVascular recently announced the launch of its Sergeant peripheral support catheter. Sergeant is a CE marked over-the-wire catheter, indicated for patients with peripheral arterial...

SVS pilots SET app for peripheral arterial disease patients

Doctor-prescribed and -supervised exercise therapy is going digital. The Society for Vascular Surgery (SVS) will begin piloting a ground-breaking app for Supervised Exercise Therapy...

SVS International Lecture: Endovascular pioneer discusses new PAD therapy

A new therapy of hydration and oncotic pressure of plasma helped 100% of certain elderly peripheral artery disease (PAD) patients in terms of pain,...

MHRA: Warning to be added to paclitaxel device IFUs in Europe

In a new field safety notice, the UK Medicines and Healthcare products Regulatory Agency (MHRA) states that a warning and clinical summary section will...

CX 2020 LIVE: Strong support for relining peripheral arteries and rivaroxaban use for widespread atherosclerosis 

In a series of Podium 1st presentations from world-class faculty, CX 2020 LIVE attendees heard the latest data on peripheral arterial disease management and an evaluation of different types of stents, including...

New guideline: ASA no longer recommended to prevent first stroke, heart...

A new Heart & Stroke guideline published today in the Canadian Medical Association Journal does not recommend taking ASA (Acetylsalicylic acid) as a preventive measure...
Wingman catheter Reflow Medical

Wingman catheter granted expanded indication to cross CTOs in PAD

Reflow Medical has announced that they have received US Food and Drug Administration (FDA) clearance for an expanded indication for the Wingman crossing catheter...

Ra Medical Systems receives FDA IDE approval to begin pivotal atherectomy...

Ra Medical Systems has announced approval from the US Food and Drug Administration (FDA) that the company has provided sufficient data to support initiating...

CMS approves coverage for PQ Bypass TORUS 2 IDE trial

PQ Bypass announced today that it has received approval for coverage from the Centers for Medicare and Medicaid Services (CMS) for the Investigational Device...

Further evaluation needed: Therapeutic angiogenesis in the treatment of PAD

Lars Norgren talks to Vascular News about therapeutic angiogenesis in the treatment of peripheral arterial disease (PAD). He points out that further evaluation in...

Positive NICE recommendation for Xarelto to prevent atherothrombotic events in CAD...

The National Institute for Health and Care Excellence (NICE) has published the final appraisal determination (FAD) recommending the use of Xarelto (rivaroxaban) by the...

LimFlow receives FDA approval for US study of minimally-invasive technology designed...

LimFlow has announced that the US Food and Drug Administration (FDA) has approved its investigational device exemption (IDE) for the PROMISE II pivotal study of...
limflow stent

LimFlow receives FDA approval for US study of minimally-invasive technology designed...

LimFlow has announced that the US Food and Drug Administration (FDA) has approved its investigational device exemption (IDE) for the PROMISE II pivotal study of...

Peripheral arterial disease risk hinges on health factors and demographics, including...

A recent study found that being a smoker, having diabetes, and also having a history of coronary heart disease or stroke increases the lifetime...

Rex Medical receives 510k clearance for Revolution Peripheral Atherectomy System

Rex Medical recently announced that it has received 510k clearance from the US Food and Drug Administration (FDA) for the Revolution Peripheral Atherectomy System. Regulatory...

CIRSE 2019: New Cook Medical paclitaxel data confirm safety of Zilver...

New data on the use of Zilver PTX, Cook Medical’s paclitaxel-coated stent for peripheral arterial disease (PAD), confirm the safety of the device. These...

Statins linked with reduced mortality in PAD patients, even when started...

Statins are linked with reduced mortality in patients with peripheral arterial disease, even when started late after diagnosis, reports a study presented recently at...

Cardiovascular Systems announces first patient enrolled in REACH PVI clinical study

Cardiovascular Systems recently announced that the first patient has been enrolled in the REACH PVI study. The purpose of this study is to prospectively...

Cardiovascular Systems announces first patient enrolled in REACH PVI clinical study

Cardiovascular Systems recently announced that the first patient has been enrolled in the REACH PVI study. The purpose of this study is to prospectively...

Tack Endovascular System launches in the USA, first commercial use announced

Intact Vascular has announced the first commercial use of its Tack Endovascular System in multiple sites across the USA. Recently FDA-approved for above-the-knee interventions,...

Tomographic 3D ultrasound imaging “the way forward” for vascular surgeons

Steven Rogers (Manchester, UK) presented the case for using contrast-enhanced tomographic 3D ultrasound imaging for peripheral arterial disease, telling the audience at Charing Cross...
SFDI

New study points to SFDI as promising technology for assessing patients...

New evidence supports the utility of spatial frequency domain imaging (SFDI) for identifying compromised circulation in patients at risk of peripheral arterial disease (PAD)....

Depression and peripheral arterial disease: A call to action

With “an indisputable association between depression and peripheral arterial disease (PAD)”—nearly a third of PAD patients experience comorbid depression or depressive symptoms—Joel Ramirez and...
cigarette

Smoking cigarettes associated with increased risk of peripheral arterial disease in...

African Americans who smoke cigarettes are more likely than those who do not smoke to develop peripheral arterial disease (PAD), according to new research...
cigarette

Smoking cigarettes associated with increased risk of peripheral arterial disease in...

African Americans who smoke cigarettes are more likely than those who do not smoke to develop peripheral arterial disease (PAD), according to new research...

Tack Endovascular System launches in the EU with first commercial use...

The first commercial use of the Tack Endovascular System (Intact Vascular) has taken place in multiple hospitals within Germany. A novel therapy for dissection...

PCSK9 inhibitors, rivaroxaban and a diabetes drug are major milestones in...

Michael Jaff (Newton, USA) outlines the major recent developments in best medical therapy that will impact the treatment of peripheral arterial disease (PAD) at...

Enrolment complete in T.I.N.T.I.N. study

iVascular has announced the completion of enrolment of patients in its T.I.N.T.I.N. (Treatment with the Luminor DCB and the iVolution self-expanding stent) study. The effectiveness...
Peripheral Orbital atherectomy system

First European patients treated with Peripheral Orbital atherectomy system

The first patients in Germany have been treated with the Stealth 360 Peripheral Orbital Atherectomy System (OAS; Cardiovascular Systems Inc). The German cases represent...
ILLUMENATE

First US patient enrolled in ILLUMENATE BTK study of Stellarex 0.014...

The first US patient has been enrolled in the Stellarex ILLUMENATE below-the-knee (BTK) investigational device exemption (IDE) study, led by principal investigators Bill Gray...

Similar patency outcomes in women and men treated with Stellarex DCB

A study presented at VIVA 2018 (5–8 November, Las Vegas, USA) by Maureen Kohi, associate professor of Clinical Radiology, University of California, San Francisco,...
Surmodics

12-Month data from PREVEIL study of SurVeil DCB presented at VIVA

Data from the PREVEIL early feasibility study of the SurVeil drug-coated balloon (DCB, Surmodics) were shared in a late-breaking clinical trial presentation at the...

TOBA II trial meets primary and secondary endpoints at one-year

The Tack Optimized Balloon Angioplasty II (TOBA II) clinical trial has successfully achieved both primary and secondary endpoints. One year results from the TOBA...

New Zilver PTX global data finds 76% freedom from TLR at...

Results from an aggregated data analysis of the use of the Zilver PTX drug-eluting peripheral stent (DES; Cook Medical) in challenging patient populations concluded...

IN.PACT SFA Trial five-year data and Total IN.PACT All-Subjects analysis presented...

  The five-year and final results from the pivotal IN.PACT SFA Trial and one-year all-subjects results from the Total IN.PACT Pooled Analysis of the IN.PACT...

Positive outcomes for Eluvia stent in long lesion IMPERIAL sub-study

Clinical outcomes from the IMPERIAL Long Lesion Sub-study were presented at VIVA (5–8 November, Las Vegas, USA) demonstrating that the Eluvia drug-eluting vascular stent...

Consider intravascular lithotripsy when treating calcified femoropopliteal arteries

 Treating severely calcified arteries by endovascular means is still a challenge, although atherectomy, stents and lithotripsy are all techniques that are employed. Lithotripsy (also...

Five-year evaluation of Zilver PTX stent in a real-world population continues...

Five-year results from a Japanese post-market surveillance study aimed at evaluating the Zilver PTX drug-eluting stent (DES) in a real-world population show consistently positive...
Xarelto

Bayer announces new licensed indication for use of Xarelto in patients...

Xarelto, co-administered with aspirin, is indicated in the EU for the prevention of atherothrombotic events in adult patients with coronary artery disease (CAD) or...

IN.PACT Admiral DCB launched in Japan

Medtronic plc has announced the full commercial launch of the IN.PACT Admiral drug-coated balloon (DCB) in Japan. The launch follows the completion of a...

LIBERTY 360° two-year data show high freedom from major amputation in...

Two-year outcomes from the LIBERTY 360° study have shown a marked improvement across all Rutherford classes, as well as high freedom from major amputation....

Ra Medical files statement for proposed initial public offering

Ra Medical Systems has filed a registration statement on Form S-1 with the US Securities and Exchange Commission relating to a proposed initial public...

Medtronic receives US FDA clearance for 200mm and 250mm IN.PACT Admiral...

Medtronic has announced that it has received US FDA approval for 200mm and 250mm lengths of the IN.PACT Admiral drug-coated balloon (DCB) to treat...

First US implants of MicroStent for peripheral arterial disease take place

MicroStent (Micro Medical Solutions), a vascular stent designed to reduce below-the-knee amputations caused by critical limb ischaemia (CLI) resulting from peripheral arterial disease (PAD)...

Sanford Health enters agreement to develop infusion system

Sanford Health and Freudenberg Medical, a global developer and manufacturer for the medical device industry, have entered into a joint research and development agreement...
Surgeon driving CorPath GRX system

US FDA clears CorPath GRX system for use in peripheral vascular...

Corindus has announced receiving 510(k) clearance from the US Food and Drug Administration (FDA) for use of the CorPath GRX system in peripheral vascular...
Medtronic IN.PACT Admiral

LINC 2018 data highlight IN.PACT Admiral as safe and effective treatment...

Medtronic added to its body of clinical evidence supporting the IN.PACT Admiral drug-coated balloon with new presentations that demonstrated durable and consistent clinical outcomes...
IN.PACT

Medtronic launches European below-the-knee clinical study of drug-coated balloon

Medtronic has launched the IN.PACT BTK study to evaluate the effectiveness of using a drug-coated balloon in patients with below-the-knee (BTK) peripheral artery disease. This...

UK All Party Parliamentary Group condemns peripheral arterial disease treatment “postcode...

The All Party Parliamentary Group on Vascular Disease has released its latest report on patient access to technologies for the diagnosis and treatment of...

EUCLID trial to analyse monotherapy of ticagrelor versus clopidogrel in patients...

Despite “overwhelming data” demonstrating the efficacy of antiplatelet therapy in heart disease and stroke, data for antiplatelet therapy for peripheral arterial disease (PAD) are...
IN.PACT

Medtronic receives FDA approval for IN.PACT Admiral DCB 150mm lengths

Medtronic has received US Food and Drug Administration (FDA) approval for the IN.PACT Admiral drug-coated balloon (DCB) in longer, 150mm lengths. The 150mm length...

Aspirin plus ticagrelor may reduce cardiovascular and limb events in peripheral...

Data from the PEGASUS-TIMI 54 trial indicate that the use of aspirin plus ticagrelor (Brilinta, AstraZeneca) in patients with prior myocardial infarction and concomitant...

Mimics trial finds higher patency for Veryan helical stent over straight...

Results from Veryan’s Mimics randomised controlled trial have been published in the latest issue of Circulation: Cardiovascular Interventions. Use of the BioMimics 3D helical...